---
$id: https://graph.org.ai/products/commodity/51282928
$type: Product
source: UNSPSC
code: "51282928"
title: "Marbofloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Marbofloxacin

**UNSPSC Code**: 51282928
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C17H19FN4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X09WU898T, chemically known as 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid but generally known as marbofloxacin, which bears US NIH Compound Identifier 60651. European Medicines Agency schedules Marbofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08648MIG. The term MARBOFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). MARBOFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule marbofloxacin under HS 29349990 and SITC 51579. As of Q4 2014, MARBOFLOXACIN remains the US FDA Preferred Term for this commodity. Marbofloxacin bears US NLM identifiers UMLS ID C0214439 and NCI Concept Code C80640. SMILES: FC1C(N2CCN(CC2)C)C2OCN(N3C2C(C1)C(=O)C(C3)C(=O)O)C.

